Surfactant lavage treatment in a model of respiratory distress syndrome

Chest

Volumn 116, Issue SUPPL., 1999, Pages 85S-86S

  Cochrane, Charles G ^a   Revak, Susan D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; INFLAMMATION; LUNG EDEMA; LUNG EXTRAVASCULAR FLUID; LUNG INJURY; LUNG LAVAGE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS SYNDROME;

EID: 0032802342     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.suppl_1.85S     Document Type: Conference Paper

References (4)

1. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991; 254: 566-568
2. Revak SD, Merritt TA, Cochrane CG, et al. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 1996; 39:715-724
3. 4-surfactant in preterm infants with RDS. Am J Respir Grit Care Med 1996; 153:404-410
4. Cochrane CG, Revak SD, Merritt TA, et al. Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome. Pediatr Res 1998; 44:1-11